These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1894198

  • 1. Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin.
    Fareed J, Walenga JM, Pifarre R, Hoppensteadt D, Koza M.
    Haemostasis; 1991; 21 Suppl 1():64-72. PubMed ID: 1894198
    [Abstract] [Full Text] [Related]

  • 2. Neutralization of recombinant hirudin: some practical considerations.
    Fareed J, Walenga JM, Hoppensteadt D, Iyer L, Pifarre R.
    Semin Thromb Hemost; 1991 Apr; 17(2):137-44. PubMed ID: 1771411
    [No Abstract] [Full Text] [Related]

  • 3. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1991 Apr 08; 65(4):355-9. PubMed ID: 2057916
    [Abstract] [Full Text] [Related]

  • 4. Haemostyptic effects of batroxobin with regard to hirudin treatment.
    Markwardt F, Kaiser B, Richter M.
    Thromb Res; 1992 Dec 15; 68(6):475-82. PubMed ID: 1341058
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 15; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of heparin and LMW heparin on hemostasis.
    Hirsh J, Buchanan MR.
    Thromb Res Suppl; 1991 Feb 15; 14():11-7. PubMed ID: 1658966
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 15; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 9. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH, Cormack JG, Morales A.
    Anesth Analg; 1995 Jul 15; 81(1):35-7. PubMed ID: 7598278
    [Abstract] [Full Text] [Related]

  • 10. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J.
    Haemostasis; 1991 Jul 15; 21 Suppl 1():49-63. PubMed ID: 1894197
    [Abstract] [Full Text] [Related]

  • 11. The effects of heparinase 1 and protamine on platelet reactivity.
    Ammar T, Fisher CF.
    Anesthesiology; 1997 Jun 15; 86(6):1382-6. PubMed ID: 9197309
    [Abstract] [Full Text] [Related]

  • 12. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G, Renga C, Weitz JI, Nenci GG, Hirsh J.
    Blood; 1992 Aug 15; 80(4):960-5. PubMed ID: 1498336
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
    Raake W, Klauser RJ, Elling H, Zeiller P.
    Haemostasis; 1991 Aug 15; 21 Suppl 1():127-32. PubMed ID: 1654293
    [Abstract] [Full Text] [Related]

  • 14. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 15; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 15. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
    Fu K, Izquierdo R, Walenga JM, Fareed J.
    Thromb Res; 1995 Jun 01; 78(5):421-8. PubMed ID: 7660358
    [Abstract] [Full Text] [Related]

  • 16. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological survey of recombinant hirudin.
    Markwardt F, Fink G, Kaiser B, Klöcking HP, Nowak G, Richter M, Stürzebecher J.
    Pharmazie; 1988 Mar 12; 43(3):202-7. PubMed ID: 3380865
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
    Bernat A, Hoffmann P, Herbert JM.
    Thromb Haemost; 1996 Nov 12; 76(5):715-9. PubMed ID: 8950779
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of recombinant hirudin and standard heparin in the Wessler model.
    Bara L, Bloch MF, Samama MM.
    Thromb Res; 1992 Oct 15; 68(2):167-74. PubMed ID: 1475779
    [Abstract] [Full Text] [Related]

  • 20. The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
    Bacher P, Walenga JM, Iqbal O, Bajusz S, Breddin K, Fareed J.
    Thromb Res; 1993 Aug 15; 71(4):251-63. PubMed ID: 8236155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.